With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top…
October 13, 2025 16:10 ET | Source: EverQuote, Inc. CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq:…
Industrial technology veteran joins the FlexIC technology pioneer enabling item-level intelligence at scale that bridges our physical and digital worlds…
The annual list highlights the world's most promising innovations tackling climate change and features an exclusive essay from Bill Gates…
October 03, 2025 16:01 ET | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics,…
September 29, 2025 19:30 ET | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…
Recognition by The Healthcare Technology Report underscores TriNetX's innovation in real-world data, artificial intelligence, and clinical research transformation. CAMBRIDGE, Mass.,…
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Eisai…
September 25, 2025 08:00 ET | Source: Oryzon Genomics, S.A. MADRID and CAMBRIDGE, Mass., Sept. 25, 2025 (GLOBE NEWSWIRE) --…
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…